These benefits, together with a past report showing that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,two aid the concept of targeting ACKR3 as a singular technique to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-connecte